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Abstract
Background: Lower respiratory tract infection (LRTI) is a major cause of pediatric morbidity and mortality, especially
among non-affluent communities. In this study we determine the impact of respiratory viruses and how viral
co-detections/infections can affect clinical LRTI severity in children in a hospital setting.
Methods: Patients younger than 3 years of age admitted to a tertiary hospital in Brazil during the months of high
prevalence of respiratory viruses had samples collected from nasopharyngeal aspiration. These samples were tested
for 13 different respiratory viruses through real-time PCR (rt-PCR). Patients were followed during hospitalization, and
clinical data and population characteristics were collected during that period and at discharge to evaluate severity
markers, especially length of hospital stay and oxygen use. Univariate regression analyses identified potential risk
factors and multivariate logistic regressions were used to determine the impact of specific viral detections as well as
viral co-detections in relation to clinical outcomes.
Results: We analyzed 260 episodes of LRTI with a viral detection rate of 85% (n = 222). Co-detection was observed
in 65% of all virus-positive episodes. The most prevalent virus was Respiratory Syncytial Virus (RSV) (54%), followed
by Human Metapneumovirus (hMPV) (32%) and Human Rhinovirus (HRV) (21%). In the multivariate models, infants
with co-detection of HRV + RSV stayed 4.5 extra days (p = 0.004), when compared to infants without the co-
detection. The same trends were observed for the outcome of days of supplemental oxygen use.
Conclusions: Although RSV remains as the main cause of LRTI in infants our study indicates an increase in the
length of hospital stay and oxygen use in infants with HRV detected by RT-PCR compared to those without HRV.
Moreover, one can speculate that when HRV is detected simultaneously with RSV there is an additive effect that
may be reflected in more severe clinical outcome. Also, our study identified a significant number of children
infected by recently identified viruses, such as hMPV and Human Bocavirus (HBov), and this is a novel finding for
poor communities from developing countries.
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Background
Lower respiratory tract infections (LRTI) represent an im-
portant public health burden in the first years of life
accounting for approximately one fifth of all deaths in
children below five years of age, especially in developing
countries [1]. The specific role of newly identified viruses
on LRTIs, like Human Metapneumovirus (hMPV), has
been studied in recent years [2]. However, its impact
among non-affluent populations has been scarcely evalu-
ated. In such locales, infants with respiratory syncytial
virus (RSV)-associated LRTIs present a three times greater
risk of a fatal event, when compared to their peers in
developed countries [3].
Although RSV is well recognized as the main agent
associated with severe LRTIs, recent data indicate that
other viruses may play a significant role in these clinical
outcomes. Human rhinovirus (HRV) seems to be of par-
ticular interest, as the most prevalent virus in respiratory
illnesses even in the first years of life [4,5], being asso-
ciated with severe acute bronchiolitis, especially among
children of atopic parents [6]. Moreover, a recent study
showed that, in a population of preterm infants, HRV
was the most prevalent agent associated with severe
bronchiolitis [7]. Also of interest is the fact that wheeze-
related HRV infection in the first year of life is asso-
ciated with an increased risk for developing asthma later
in life [8], and that this effect was greater than the
observed in relation to RSV [9].
The impact on severity of early life respiratory infec-
tions may be also affected by viral co-detections diag-
nosed through sensitive PCR analyses. Some studies
have shown a positive association between viral co-
detection and worse clinical outcomes [10,11], while
others have failed to show results in the same direction
[12-14].
The aims of our study were to determine the current
impact of newly identified viruses on the severity of
LRTI in infants seen in the emergency room and
pediatric wards from a tertiary hospital in a developing
country, and how specific viruses alone or in co-
detections increased the degree of clinical severity of
disease.
Methods
Subjects and study design
Infants and toddlers younger than three years of age,
with a diagnosis of LRTI, admitted to the emergency
room (ER) or pediatric wards of a tertiary hospital in
Porto Alegre, southern Brazil, were recruited for this
study, during the months of greatest prevalence for
acute pediatric respiratory viral illnesses (i.e., from April
to November) in 2007 [4,15]. The great majority of
patients seen in this particular setting come from low-
income families, with health coverage provided by the
Brazilian free-access public health system.
LRTI was defined by the presence of signs and symp-
toms of an acute respiratory infection (cough, nasal dis-
charge, oropharyngeal hyperemia, with or without fever),
and lower respiratory signs (tachypnea, retractions, pro-
longed expiratory time, or crackles/wheezing on auscul-
tation). Chest radiographs were taken only at medical
assistant discretion, to avoid unnecessary X-ray expos-
ure, and thus were not used for diagnostic purposes.
Children who were admitted in the ER with signs and
symptoms of a LRTI for at least 6 hours were considered
eligible, once symptoms had started within the previous
5 days. Patients with other co-morbidities such as neuro-
muscular diseases, previous cardiopulmonary disorders,
immunodeficiencies, or important congenital anomalies
were excluded. We also excluded patients with a
hospitalization due to LRTI in the previous 30 days. Bac-
terial pneumonia was excluded by clinical presentation
and chest X-rays findings.
Within the first 24 hours of hospitalization, medical
information was collected from parents or guardians
through a standardized questionnaire. Data regarding
clinical conditions at admission, vital signs, and signs of
respiratory distress were obtained from the medical
charts. Information on use of medications, clinical
course of the disease until discharge, use of supplemen-
tal oxygen, and length of hospital stay were prospectively
collected. These two latter variables were used as the
main clinical outcomes, serving as surrogates for clinical
severity. Supplemental oxygen was withdrawn when
pulse oximetry was equal or greater than 94% in room
air for at least 6 hours, as this is the standard clinical
procedure in the hospital. Sample size was estimated
based on few previous similar studies, since data analyz-
ing the association between viral co-detection and our
main outcomes was scarce at the time this project was
planned [16-18].
Nasopharyngeal sample collection
Nasopharyngeal aspiration with a standardized tech-
nique using vacuum and a sterile collector were per-
formed in all children within the first 48 hours of
admission. Samples were immediately split into aliquots,
including one in TRIzolW, and stored at −80°C, until
shipment to the Laboratory of Viral Pathogenesis, at the
University of São Paulo School of Medicine, Ribeirão
Preto.
Viral detection by individual real-time RT-PCR
To isolate RNA from nasal aspirates, 250 μL were
extracted according to the manufacturer’s protocol
(Invitrogen, Carlsbard, USA). DNA was extracted from
a sample of 200 μL of nasal aspirate using the Wizard
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Genomic DNAW purification kit, following manufac-
turer’s instructions (Promega, Madison, USA). The de-
tection of viruses was done by Real Time PCR, using
the Taqman SystemW (Applied Biosystems, New Jersey,
USA), with specific primers and probes in a thermal cycler
(7300 Real Time PCR systemW - Applied Biosystems). Real
Time PCR reactions for cellular gene (β-actin) were also
performed for internal quality control.
For viruses with a RNA genome (i.e., HRV, Influenza
Virus-A [FLUAV], human parainfluenza virus [HPIV],
RSV, hMPV and human coronavirus [HCoV]), the tran-
scription into cDNA was done with reverse transcriptase
(high capacity cDNA reverse transcription kitW, Applied
Biosystems), using 1 μg from the extracted RNA, accord-
ing to the manufacturers’ protocol. The qPCR assays were
performed using 3 μL of the DNA extraction or cDNA
(approximately 150 ng), 0.33 pmoles for primers, 0.17
pmoles for probes and 7.5 μL of master mix of TaqManW
(Applied Biosystems). Amplifications were performed with
45 cycles of denaturation at 95°C for 15 seconds and
annealing-extension at 60°C for one minute, except for
hMPV, when annealing was done at 55°C for 30 seconds,
and extension at 60°C for one minute.
Statistical analysis
Demographics were summarized as mean or median and
range according to their distribution. Characteristics
among groups were compared, accordingly, using two-
sample t-test, Mann–Whitney, Chi-square or Fisher’s
exact test.
Generalized linear models (Tweedie model with Iden-
tity link function) were used to analyze the relationships
between main outcomes (length of stay in the hospital
and time in use of supplemental oxygen) and the pre-
dictor variables (virus detection [yes/no], sex, age, pre-
maturity (i.e. <37 weeks of gestation), maternal smoking
during pregnancy, family asthma). All variables with a
significance of p < 0.15 were considered in the univariate
models and those with significance of p < 0.05 in the
multivariate analysis. All analyses were performed using
SPSS v.18 (SPSS Inc, Chicago, IL).
This study was approved by the local Institutional
Ethics Committees (06/03467 - Pontif ícia Universidade
Católica do Rio Grande do Sul and 4856/2004 – Univer-
sidade de São Paulo). Parents or legal guardians read
and signed an informed consent approved for this study.
Results
Two hundred and sixty patients were enrolled in the
study. Characteristics of the patients recruited are pre-
sented in Table 1. In the whole sample there were more
boys than girls, almost half of children were younger
than six months, 24% of all children were born prema-
ture, 29% had been exposed to tobacco during gestation,
and more than a half had a family history of asthma
(parents or siblings). Overall, median hospital length was
6 days and median supplemental oxygen requirement
was 5 days.
The presence of viruses was detected by PCR in 222
(85%) of all LRTI episodes. Co-detection was present in
146/260 (56%). The frequencies of viral detection and
co-detection are shown in Table 2. The most common
single infection was related to RSV (54%), followed by
hMPV (32%), and HRV (21%).
During the surveyed time RSV has shown an incidence
peak in the beginning of the cold season (i.e. from april
to November) in the southern hemisphere, followed in
late winter by peaks of hMPV, HRV, and HBov (Figure 1).
Other viruses such as HPIV and Human Adenovirus
Table 1 Characteristics and outcomes of the population
included in the study (260 children)
Sex, female, n (%) 103 (40)
Age, months, median (range) 5 (1-35)
Age, <6 months, n (%) 128 (49)
Maternal smoking during pregnancy, n (%) 74 (29)
Prematurity, n (%) 62 (24)
Family history of asthma*, n (%) 149 (58)
LOS+, days, median (range) 4 (2-8)
Use of oxygen, days, median (range) 3 (1-6)
+ LOS: length of hospital stay; * for parents and/or siblings.
Table 2 Viral detection by RT-PCR, among 260 children
Overall prevalence of viruses n (%)
No vírus detected 38 (14.1)
RSV 139 (53.5)
hMPV 84 (32.3)
HRV 54 (20.8)
HBov 27 (10.4)
Influenza (A or B) 33 (12.7)
Para-influenza (1 or 2) 17 (6.5)
Adenovirus 17 (6.5)
Coronavirus 3 (1.2)
Co-detections n (%)
RSV + HRV 22 (8.5)
RSV + HMPV 37 (14.2)
RSV + Others* 26 (10.0)
HRV + Others** 29 (11.2)
HMPV + Others*** 16 (6.1)
HMPV + Others*** 16 (6.1)
RSV: Respiratory sincytial virus; HMPV: Human metapneumovirus; HRV:
Human rhinovirus.
* Bocavirus + influenza A or B.
** HMPV + influenza A or B.
*** Bocavirus + influenza A or B.
da Silva et al. BMC Infectious Diseases 2013, 13:41 Page 3 of 8
http://www.biomedcentral.com/1471-2334/13/41
(HAdv) showed low but constant rates throughout the
season.
In the univariate analyses, length of hospital stay and
need of supplemental oxygen were significantly asso-
ciated with age (≤6 months), maternal smoking during
pregnancy and with family history of asthma (parents
and/or siblings) (Table 3). Infants younger than 6 months
of age stayed in hospital 3.8 days longer than older
infants (p < 0.001), and those with a family history of
asthma stayed 2.4 days longer than those without a fam-
ily history of asthma (p < 001). Also, infants 6 months of
age or younger needed supplemental oxygen for an extra
3.8 days, when compared to older infants/children. A
similar finding was observed for children with a family
history of asthma, who required 2.4 extra days of oxygen
compared to those without the family history of asthma
(Table 3). Other risk factors, such as breastfeeding, in-
door smoking, current parental smoking, siblings, and
overcrowding were not significantly associated with nei-
ther of the main outcomes.
Infants with positive PCR for HRV alone as well as
those co-detected with RSV and HRV also had signifi-
cantly longer hospital stays (3.2 days, p = 0.001; and
5.5 days, p = 0.002, respectively) than those with other
detected viruses. Extended time in use of supplemental
oxygen was also associated with HRV (2.8 days, p =
0.002) and RSV (3.7 days, p = 0.013), but also with Influ-
enza virus A or B (2.2 days, p = 0.042), when compared
to those with other viruses in single or in co-detection.
Infants with HRV-LRTIs stayed an extra 2.2 days in hos-
pital (p = 0.011), for a total of 7.7 (95% CI: 6.1-9.3) days
when compared to those with other infections, after adjust-
ing for potential confounding variables (Table 4). Table 5
shows that infants with combined HRV and RSV positive
PCR in the same samples stayed 4.5 extra days (p = 0.004)
than those without HRV and RSV in these adjusted models
(that included sex, age ≤ 6 versus >6 months, prematurity,
family history of asthma and maternal smoking during
pregnancy), (95% CI: 7.0-13.0) days. Time in use of supple-
mental oxygen followed the same association trends.
Infants with proven RSV infections needed 4.75 (95% CI:
3.97-5.53) extra days of oxygen, while those with HRV used
supplemental oxygen for 1.4 extra days, and those with
RSV and HRV co-detection for 2.2 days, when compared
to infants presenting positive PCRs for other viruses alone
or in combinations. Figure 2 illustrates the association be-
tween HRV and RSV +HRV co-detection with increased
length of hospital stay and oxygen use, and this effect is es-
pecially significant for infants younger than 6 months of
age. Influenza viruses were not associated with longer use
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Figure 1 Monthly numbers of samples positive for the different viruses from the subjects studied.
Table 3 Univariate analyses of risk factors for length of hospital stay and days with supplemental oxygen (n = 260)
Length of hospital stay Days with supplemental oxygen
β* (95% CI) p β* (95% CI) p
Sex, female 0.4 (-0.9 - 1.7) 0.553 0.5 (-0.6 - 1.7) 0.372
Age, <6 months 3.8 (2.7 - 5) <0.001 3.8 (2.8 - 4.9) <0.001
Prematurity 0.4 (-1.0 - 1.9) 0.570 0.4 (-1.0 - 1.7) 0.605
Maternal smoking during pregnancy 1.2 (-0.2 - 2.6) 0.106 1.3 (-0.02 - 2.7) 0.054
Family Hx asthma 2.4 (1.2 - 3.6) <0.001 2.4 (1.3 - 3.5) <0.001
Hx: history; * number of extra days, compared to negative counterparts.
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of supplemental oxygen when controlling for the demo-
graphic variables.
Discussion
Our results suggest that infants with severe LRTI and
positive PCR for HRV, alone or in co-detection with
RSV, stayed hospitalized longer periods and utilized
more supplemental oxygen, when compared to children
infected by other viruses, including those with RSV-
alone. Our data also reinforce previous findings that
identified RSV as the major agent associated with severe
LRTIs among children in a hospital setting, in popula-
tions of low socio-economic status, where other environ-
mental and social variables potentially play a role
[16,17]. Infants younger than six months and those with
a family history of asthma/recurrent wheeze are also at
greater risk for disease severity.
RSV was the most frequently detected virus, account-
ing for a high burden of LRTIs in our population. Al-
though it is not possible to establish an unequivocal
correlation between LRTIs and upper airway viral detec-
tion, the finding of RSV in over 50% of hospitalized chil-
dren in our study strongly suggests that its impact is still
indeed very high in this region, regardless of the pres-
ence of newly identified viruses. These results are in ac-
cordance with recently published studies in Brazil, which
also identified RSV as the main agent responsible for se-
vere LRTI, especially in a hospital setting. Nascimento
and coworkers have shown an overall viral detection rate
of 93% from nasopharyngeal samples in a small group of
children below 2 years of age, and reported RSV as the
most prevalent virus (63.6%) [19]. Another study aiming
to investigate the role of HBov and hMPV in LRTIs in
southern Brazil also showed similar results (at least one
positive virus in 90% of the samples and RSV positive in
49.3%) [20]. The high detection rate of RSV in children
with LRTI in a hospital setting such as ours is consistent
with most studies worldwide and the burden due to viral
respiratory disease seems as high in these locales as they
are in more developed countries. A recent analysis of
children admitted into the hospital due to acute bron-
chiolitis in Texas, USA, has shown a steady increase in
admissions over a 5-year period and this has been cred-
ited mostly to RSV [21]. This increasing role for severe
viral LRTIs, observed also in other studies, is probably
explained by a series of complex environmental and so-
cial changes that seem to affect how viruses spread in
communities.
Some studies have reported different clinical outcomes
for specific viruses causing LRTIs, especially in the pres-
ence of co-detections, such as with RSV and HBov
[22,23], while others did not reproduce such findings
[17,24,25] and these associations remain unclear. A lack
of association between an overall finding of any viral co-
detection and LRTI severity was reported in studies per-
formed in non-affluent countries [2,12,26], as well as in
developed countries [13,14]. In our study, patients
detected with HRV alone and RSV +HRV presented
Table 4 Multivariate analysis for length of hospital stay (dependent variable), and HRV adjusting other risk factors
Yes No
β* 95% CI P
Mean (95% CI) Mean (95% CI)
HRV 7.7 (6.1 - 9.3) 5.5 (4.7 - 6.2) 2.2 (0.5 - 3.9) 0.011
Sex (female) 6.8 (5.6 - 8.0) 6.3 (5.4 - 7.3) 0.4 (-0.6 - 1.5) 0.419
Age <6 months 8.2 (7.0 - 9.3) 5.0 (3.9 - 6.0) 3.2 (2.0 - 4.3) <0.001
Family Hx of asthma 7.2 (6.2 - 8.2) 6.0 (4.8 - 7.1) 1.2 (0.1 - 2.3) 0.035
Prematurity 6.7 (5.4 - 7.9) 6.5 (5.5 - 7.4) -0.2 (-1.4 - 1.0) 0.749
Maternal smoking 6.8 (5.6 - 8.2) 6.3 (5.3 - 7.2) 0.6 (-0.6 - 1.8) 0.354
Hx: history; * number of extra days in hospital, compared to negative counterparts.
Table 5 Multivariate analysis for length of hospital stay (dependent variable) and HRV + RSV (co-detection), adjusting
for other risk factors
Yes No β*
(95% CI)
P
Mean (95% CI) Mean (95% CI)
RSV + HRV 10.0 (7.0 - 13.0) 5.5 (4.8 - 6.3) 4.5 (1.4 - 7.5) 0.004
Age, <6 months 9.4 (7.7 - 11.1) 6.1 (4.6 - 7.7) 3.3 (2.2 - 4.5) <0.001
Sex (female) 7.9 (6.2 - 9.6) 7.6 (6.0 - 9.2) 0.3 (-0.7 - 1.4) 0.517
Family Hx of asthma 8.3 (6.7 - 9.9) 7.2 (5.5 - 8.9) 1.1 (0.04 - 2.2) 0.043
Prematurity 7.8 (6.1 - 9.5) 7.7 (6.1 - 9.4) -0.04 (-1.2 - 1.2) 0.952
Maternal smoking 8.1 (6.3 - 9.9) 7.4 (5.9 - 8.9) 0.7 (-0.5 - 2.0) 0.243
Hx: History; * number of extra days in hospital, compared to negative counterparts.
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increased length of hospitalization and increased time of
supplemental oxygen use. Papadopoulos et al. has shown
a five-fold increase in clinical severity in infants with
acute bronchiolitis due to HRV, compared to those
infected only with RSV. Compared to those with positive
RSV samples without HRV co-detection, infants with
HRV were older, had lower birth weights and were hos-
pitalized earlier [16]. Some explanations for apparently
contradictory findings in a myriad of studies could be
attributed to the lack of uniform criteria for subject in-
clusion and standardized statistical analysis [14]. Other
plausible explanations are the natural variation in HRV
prevalence in different seasons and possible variations in
the prevalence of type C HRV. This agent is associated
with more severe disease and was already described as a
major cause of LRTI in infants from non-affluent coun-
tries [27,28]. Unfortunately, in our study, we were not
able to determine the prevalence of HRV subtypes, and
this stands as an interesting subject for further research.
The association of HRV (alone or with RSV) with
LRTI severity and atopy has not been widely studied.
The relationship between persistent wheezing at 3 years
and at 6 years versus relevant HRV infection in early life
is well established [9,29], but there are few studies look-
ing at these relationships in the first year of life. A recent
study suggests that the relationship between HRV in
early life LRTI and subsequent recurrent wheeze/asthma
is dependent on allergic sensitization, which seems to
precede the viral insult in a causal model [30]. This asso-
ciation we have found between HRV with increased
Figure 2 Comparison of RSV, HRV and RSV plus HRV in regards to: (A) length of hospital stay and (B) days of supplemental oxygen
use. Black circles: group of infants≤ 6 months of age; white circles: group of infants > 6 months of age. The groups of HRV and RSV + HRV were
significantly different (p < 0.05), when compared by age. Values expressed as mean ± SD of days.
da Silva et al. BMC Infectious Diseases 2013, 13:41 Page 6 of 8
http://www.biomedcentral.com/1471-2334/13/41
severity (using the surrogates of length of hospital stay
and days in supplemental oxygen) is a major finding.
Hence, the association between HRV infection, increased
severity and atopy remains to be better clarified.
It has already been shown that HRV is able to reduce
cell proliferation and decreases the self-repair capacity of
bronchial epithelial cells [31]. Therefore, our data may
suggest that in certain subsets of patients the burden of
HRV in acute LRTI should be considered distinct from
that of other viruses. Another plausible explanation for
our findings could be the possibility of HRV persistence
in the airways leading to an “over detection” of the virus,
simultaneously with those infected only by RSV [32]. In
our study this hypothesis seems improbable since we
detected a clear worsening in the clinical markers in
patients with RSV that were also detected with HRV.
Another interesting finding of our study was the high
prevalence of newly described viruses. hMPV was
detected in almost one third of all episodes, but did not
seem to affect the main outcomes studied here, in the
way RSV and HRV have done. While the recognition of
the impact of human hMPV is increasing, its prevalence
is still probably underestimated in clinical practice, since
laboratory testing has become widely available only in
recent years [18,24,33]. HBov was also detected in a
large number of nasal samples and it was very frequently
associated (co-detected) with other agents. In our study,
only 2/27 patients with HBov had this virus detected as
single agent. The overall HBov detection rate was higher
in our data compared to previous studies [34,35], and
this may be explained again by natural seasonal varia-
tions. It is also interesting to notice the seasonal pattern
of both hMPV and HBov, which present their peak
prevalence rates in late winter, right after the RSV peak,
which occurs earlier in winter.
The main limitation of our study is the lack of surveil-
lance in consecutive years, which could have biased
results in case of an outbreak of one specific virus in a
given year. Our eight months of viral surveillance could
potentially have failed to detect any atypical outbreak,
which did not seem likely to have occurred. Also, reli-
able tests capable of ruling out bacterial co-detection
were not available at the time of the study. This could
have underestimated the burden of bacteria in our sam-
ple and the co-detection of viruses and bacteria remains
an interesting issue for further studies.
Conclusion
In our study, RSV was the most prevalent viral agent in
hospitalized patients with LRTI and the co-detection of
HRV in patients with RSV infection increased hospital
stay and days in use of supplemental oxygen. Interest-
ingly, even in developing countries, the role of recently
discovered viruses needs to be further studied in order
to identify novel risk factors of susceptibility/severity,
and new treatment targets for these agents. We also
highlight the role of HRV as an important risk factor for
severe LRTI, particularly when simultaneously associated
with RSV, which strongly suggests that co-detection may
also mean co-infection, since the combination of the
two agents seem to affect clinical outcomes. Longitu-
dinal studies with control groups are necessary to con-
firm these results in populations at greater risk for
severe respiratory disease.
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